Koskimies O, Vilska J, Rapola J, Hallman N
Arch Dis Child. 1982 Jul;57(7):544-8. doi: 10.1136/adc.57.7.544.
One hundred and fourteen children with primary nephrotic syndrome were followed up prospectively for periods of between 5 and 14 years. Urine samples from 94 of them became protein-free during the initial 8-week course of prednisone, and the outcome for these children was good: 74 of them have been free of symptoms for at least 3 years, 18 have had relapses during the last 3 years, and only one child still has proteinuria. All these children have normal renal function and blood pressure. One child died accidentally. Twenty children did not respond to the initial prednisone treatment. Thirteen of them had remissions later, of whom 2 have had relapses during the last 3 years. Seven were totally resistant to prednisone 4 of whom died in renal failure, the remaining 3 have persistent proteinuria with normal levels of creatinine; one has high blood pressure too. Remission during the initial treatment indicated a good prognosis, but two-thirds of the initial non-responders also fared well.
对114例原发性肾病综合征患儿进行了为期5至14年的前瞻性随访。其中94例患儿在最初8周的泼尼松治疗过程中尿蛋白转阴,这些患儿的预后良好:74例至少3年无症状,18例在过去3年中有复发,只有1例患儿仍有蛋白尿。所有这些患儿的肾功能和血压均正常。1例患儿意外死亡。20例患儿对最初的泼尼松治疗无反应。其中13例后来缓解,其中2例在过去3年中有复发。7例对泼尼松完全耐药,其中4例死于肾衰竭,其余3例肌酐水平正常但持续有蛋白尿;1例还有高血压。初始治疗期间缓解表明预后良好,但最初无反应者中有三分之二预后也较好。